LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancer: experimental drug BL-B01D1 enters human trials
Disease control Recruiting nowThis early-phase study tests a new drug called BL-B01D1 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. About 570 participants will be enrolled to also see if the drug can shri…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 16, 2026 22:30 UTC
-
New drug shows promise for Hard-to-Treat breast cancers
Disease control Recruiting nowThis early-stage trial tests a new drug, BL-M07D1, in people with advanced breast cancer or other solid tumors that have a specific protein called HER2. The study aims to find a safe dose and check for side effects. About 26 adults whose cancer has not responded to standard treat…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New study tracks cancer Drug's journey through the body
Knowledge-focused Recruiting nowThis study looks at how the drug saruparib is absorbed, distributed, broken down, and removed from the body in 8 people with advanced solid tumors. Participants receive a single oral dose and a single IV dose with a tiny radioactive tracer to track the drug. The goal is to unders…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 16, 2026 22:33 UTC